Melanotan II

Research

Melanotan II

Aliases
MT-2, MT-II
Administration
Subcutaneous injection (unregulated, self-administered)

Timing

A general projection of what people report noticing over time, based on the known mechanism and reported use patterns. It is not a guarantee and individual experience varies considerably.

  1. 1

    1–2 Weeks

    Users commonly report visibly darker skin within the first one to two weeks of the loading phase.

  2. 2

    3–4 Weeks

    Tanning effects are typically well established by this stage, alongside possible nausea or flushing during dosing.

  3. 3

    5–7 Weeks

    Many users transition to a lower maintenance dose around this period.

  4. 4

    8–10 Weeks

    Skin pigmentation is generally maintained with continued lower-dose use.

  5. 5

    11–15 Weeks

    Libido-related side effects, where present, tend to remain consistent with continued use.

  6. 6

    16–20 Weeks

    Long-term users typically describe a stable, maintained tan with ongoing use.

  7. 7

    21–24 Weeks

    By this stage, users have generally settled into a personal maintenance routine, weighing cosmetic effect against unregulated safety risk.

⚠️ Research context only. This is not medical advice and results are not guaranteed.